PTPN23 Products

Description

Chimera RNA interference (chimera RNAi) is process by which small interfering RNA/DNA chimera triggers the destruction of mRNA for the original gene.  The discovery work, design, and application of chimera RNAi has been pioneered by Professor Kaoru Saigo and Dr. Kumiko Ui-Tei at the University of Tokyo.  Chimera RNAi has many advantages over the conventional siRNAs.  First, it has been demonstrated to have reliable knock-down for over 10,000 human genes.  Because the human genome is composed of an intricate, genetic network, chimera RNAi's unique design has successfully obviated the off-target effects including microRNA-based influence.  Another advantage of the chimera RNAi technology is its effectiveness at low concentrations (0.5nM to 5nM); only mRNA is destroyed so genomic genes are not affected.  Finally, having both the sense and anti-sense strands consisting RNA/DNA chimera, it offers much greater compound stability for streamlining in vitro and in vivo assays and applications while minimizing interferon induction and other adverse reactions.

Bioinformatics

Product By Gene ID	25930
Alternate Names	EC 3.1.3.48 HDPTP HD-PTP HD-PTPDKFZp564F0923 His domain-containing protein tyrosine phosphatase His-domain protein tyrosine phosphatase KIAA1471 KIAA1471DKFZP564F0923 Protein tyrosine phosphatase TD14 protein tyrosine phosphatase, non-receptor type 23 PTPN23 PTP-TD14 tyrosine-protein phosphatase non-receptor type 23